Curis
CRIS
#10201
Rank
S$22.61 M
Marketcap
S$1.75
Share price
0.00%
Change (1 day)
-66.91%
Change (1 year)

P/E ratio for Curis (CRIS)

P/E ratio as of December 2025 (TTM): -0.3723

According to Curis's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.372289. At the end of 2024 the company had a P/E ratio of -0.4353.

P/E ratio history for Curis from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-0.4353-69.21%
2023-1.4157.16%
2022-0.8994-90.55%
2021-9.52-22.12%
2020-12.2597.48%
2019-1.75151.46%
2018-0.6970
2016-6.8417.6%
2015-5.82-18.52%
2014-7.14-62.01%
2013-18.89.62%
2012-17.2-56.03%
2011-39.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Exelixis
EXEL
18.7-5,115.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
8.44-2,366.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-2.86 668.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-8.67 2,228.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
15.1-4,164.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
17.6-4,836.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-0.5660 52.04%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.